| Stanford University | Julien Sage | SEED Grant | Functions of RB family proteins in human embryonic stem cells | $520,777 |
| University of California, Los Angeles | Amander Clark | New Cell Lines | Generation of Pluripotent Cell Lines from Human Embryos | $1,177,648 |
| San Francisco State University | Carmen Domingo | Bridges | Bridges to Stem Cell Research | $3,594,705 |
| Cedars-Sinai Medical Center | Dan Gazit | Early Translational II | Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures | $1,927,698 |
| University of California, Los Angeles | Antoni Ribas | Disease Team Therapy Development - Research | Genetic Re-programming of Stem Cells to Fight Cancer | $19,999,563 |
| University of California, San Diego | Lawrence Goldstein | Comprehensive Grant | Using Human Embryonic Stem Cells to Understand and to Develop New Therapies for Alzheimer's Disease | $2,512,664 |
| University of California, Merced | Michael Cleary | Tools and Technologies I | RNA Analysis by Biosynthetic Tagging (RABT): a tool for the identification of cell type-specific RNAs | $483,803 |
| University of California, San Francisco | Robert Blelloch | SEED Grant | MicroRNA Regulation of Human Embryonic Stem Cell Self-Renewal and Differentiation | $631,831 |
| University of California, Los Angeles | Reza Ardehali | New Faculty Physician Scientist | Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors | $3,105,388 |
| University of California, San Diego | Lawrence Goldstein | Disease Team Research I | Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis | $10,857,762 |
| University of Southern California | Roberta Brinton | Creativity Awards | CIRM STAR High School Summer Research and Creativity Program | $264,000 |
| Stanford University | Helen Blau | Early Translational III | Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients | $1,825,920 |
| University of California, Berkeley | Irina Conboy | New Faculty I | Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues | $2,246,020 |
| University of California, Davis | Ebenezer Yamoah | SEED Grant | Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells | $469,327 |
| University of California, San Diego | Shu Chien | Tools and Technologies II | Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation | $1,832,515 |
| Stanford University | Joseph Wu | Early Translational III | Heart Repair with Human Tissue Engineered Myocardium | $4,766,231 |
| University of California, Los Angeles | Yong Kim | Basic Biology II | Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells | $1,259,371 |
| Geron Corporation | Jane Lebkowski | Disease Team Therapy Planning I | Preclinical Development and First-In-Human Testing of [REDACTED] in Advanced Heart Failure | $106,239 |
| University of California, Los Angeles | Antoni Ribas | New Faculty II | Stem Cells for Immune System Regeneration to Fight Cancer | $3,247,000 |
| University of Southern California | Peter Laird | SEED Grant | Screening for Oncogenic Epigenetic Alterations in Human ES Cells | $685,000 |
| University of California, Merced | John White | Major Facilities | No Title | $4,359,480 |
| The Salk Institute for Biological Studies | Juan Carlos Izpisua Belmonte | Research Training II | Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II | $3,062,677 |
| Stanford University | Roel Nusse | Basic Biology IV | Asymmetric stem cell division oriented by a local self-renewing signal | $1,195,811 |
| University of California, San Diego | Farah Sheikh | Basic Biology III | Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC | $1,341,955 |
| ViaCyte, Inc. | Olivia Kelly | Early Translational I | Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product | $5,405,397 |
| University of California, Davis | Paul Knoepfler | New Faculty II | Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency | $2,158,161 |
| Stanford University | Susan McConnell | SEED Grant | Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease | $633,170 |
| Children's Hospital of Oakland Research Institute | Mark Walters | Disease Team Planning | CIRM Disease Team Planning Award | $55,000 |
| The Salk Institute for Biological Studies | Inder Verma | Shared Labs | Shared viral vector facility for genetic manipulation of human ES cell | $4,316,515 |
| Stanford University | Michelle Monje | Basic Biology IV | Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain | $1,264,248 |
| Beckman Research Institute of City of Hope | Yanhong Shi | Early Translational II | Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell | $1,835,983 |
| University of California, San Francisco | Mark Anderson | Transplantation Immunology | Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells | $1,314,090 |
| Stanford University | Roel Nusse | Comprehensive Grant | Guiding the developmental program of human embryonic stem cells by isolated Wnt factors | $2,354,820 |
| Scripps Research Institute | Peter Schultz | SEED Grant | A Chemical Approach to Stem Cell Biology | $784,900 |
| The J. David Gladstone Institutes | Bruce Conklin | New Cell Lines | Induced Pluripotent Stem Cells for Cardiovascular Diagnostics | $1,708,560 |
| San Jose State University | Tzvia Abramson | Bridges | Stem Cell Internships for Laboratory-based Learning (SCILL) | $3,614,907 |
| Stanford University | Michele Calos | Early Translational II | Stem Cell Therapy for Duchenne Muscular Dystrophy | $2,325,933 |
| University of California, Irvine | leif Havton | Early Translational II | Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons | $1,614,441 |
| University of California, Davis | Nancy Lane | Disease Team Therapy Development - Research | Treatment of osteoporosis with endogenous Mesenchymal stem cells | $19,999,867 |
| University of California, San Diego | Martin Marsala | Comprehensive Grant | Spinal ischemic paraplegia: modulation by human embryonic stem cell implant | $2,445,716 |
| University of California, Santa Cruz | Joel Kubby | Tools and Technologies I | AO Wide-Field Microscope | $552,985 |
| Buck Institute for Age Research | Dale Bredesen | SEED Grant | Programmed Cell Death Pathways Activated in Embryonic Stem Cells | $734,202 |
| ViaCyte, Inc. | Howard Foyt | Strategic Partnership I | Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes | $10,075,070 |
| Beckman Research Institute of City of Hope | Paul Salvaterra | Creativity Awards | Creativity Award Program in Stem Cell Biology for California High School Students | $211,200 |
| University of California, San Diego | Mark Tuszynski | Early Translational III | Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury | $4,699,569 |
| University of California, Santa Cruz | Bin Chen | New Faculty I | Molecular mechanisms of neural stem cell differentiation in the developing brain | $2,200,715 |
| University of California, Irvine | Kyoko Yokomori | SEED Grant | Derivation and characterization of human ES cells from FSHD embryos | $632,500 |
| University of California, Berkeley | Steven Conolly | Tools and Technologies II | Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo | $1,452,360 |
| University of California, Irvine | Thomas Lane | Early Translational III | Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells | $4,799,814 |
| Stanford University | Steven Artandi | Basic Biology II | Self-renewal and senescence in iPS cells derived from patients with a stem cell disease | $1,430,908 |
| University of Southern California | Roberta Brinton | Disease Team Therapy Planning I | A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer's Disease | $107,989 |
| The J. David Gladstone Institutes | Benoit Bruneau | New Faculty II | Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors | $2,847,600 |
| University of California, Irvine | Thomas Lane | SEED Grant | Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination | $425,594 |
| University of California, Santa Barbara | Glenn Lucas | Major Facilities | No Title | $3,205,800 |
| University of California, Santa Barbara | Dennis Clegg | Research Training II | Training Program in Stem Cell Biology and Engineering | $2,451,273 |
| University of California, San Diego | Eugene Yeo | Basic Biology IV | Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration | $1,393,200 |
| University of California, San Diego | David Cheresh | Basic Biology III | Molecular basis of human ES cell neurovascular differentiation and co-patterning | $1,361,448 |
| Scripps Health | Darryl D'Lima | Early Translational I | Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis | $3,118,431 |
| University of California, Berkeley | Lin He | New Faculty II | The roles of non-coding RNAs in the self-renewal and differentiation of pluripotent stem cells | $1,499,994 |
| University of California, Irvine | Charles Limoli | SEED Grant | Using human embryonic stem cells to treat radiation-induced stem cell loss: Benefits vs cancer risk | $625,617 |
| Cedars-Sinai Medical Center | Eduardo Marbán | Disease Team Planning | {REDACTED} Heart Disease Regenerative Medicine Team Planning Award | $46,886 |
| University of California, Irvine | Peter Donovan | Shared Labs | Regional Human Embryonic Stem Cell Shared Research Laboratory and Stem Cell Techniques Course | $5,572,979 |
| Cedars-Sinai Medical Center | Eduardo Marbán | Basic Biology IV | Mechanism of heart regeneration by cardiosphere-derived cells | $1,367,604 |
| Buck Institute for Age Research | Xianmin Zeng | Early Translational II | Banking transplant ready dopaminergic neurons using a scalable process | $6,016,624 |
| La Jolla Institute for Allergy and Immunology | Anjana Rao | Transplantation Immunology | Generation of regulatory T cells by reprogramming | $1,503,998 |
| University of California, Davis | Alice Tarantal | Comprehensive Grant | Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells | $2,257,040 |
| University of California, Irvine | Vincent Procaccio | SEED Grant | Mitochondrial Dysfunction in Embryonic Stem Cells | $632,500 |
| University of California, San Diego | Steve Dowdy | New Cell Lines | Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin. | $1,387,800 |
| The Salk Institute for Biological Studies | Fred Gage | Early Translational II | Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model | $2,472,839 |
| University of California, Davis | John Laird | Disease Team Therapy Development - Research | Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia | $14,184,595 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Comprehensive Grant | Chemical Genetic Approach to Production of hESC-derived Cardiomyocytes | $3,036,002 |
| University of California, Irvine | Orhan NALCIOGLU | Tools and Technologies I | A Multimodality Molecular Imaging Systen (MRSPECT) for in Vivo Stem Cell Tracking | $719,798 |
| Human BioMolecular Research Institute | John Cashman | SEED Grant | Discovering Potent Molecules with Human ESCs to Treat Heart Disease | $714,654 |
| Bluebird Bio | David Davidson | Strategic Partnership I | A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia by Transplantation of Autologous Hematopoietic Stem Cells [REDACTED] | $9,363,335 |
| Gamma Medica-Ideas, Inc. | James Hugg | Tools and Technologies II | Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring | $1,528,599 |
| Scripps Research Institute | James Williamson | Creativity Awards | Stem Cell Summer Academy: Creating the Next Generation of Scientists | $206,250 |
| University of California, San Diego | Karl Willert | Basic Biology I | WNT signaling and the control of cell fate decisions in human pluripotent stem cells. | $1,376,802 |
| Stanford University | Renee Reijo Pera | Early Translational III | Autologous iPSC Therapy for Urinary Incontinence | $5,279,607 |
| Stanford University | Karl Deisseroth | New Faculty I | Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny | $3,154,719 |
| University of California, Los Angeles | Siavash Kurdistani | SEED Grant | Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells | $641,047 |
| University of California, San Diego | Lawrence Goldstein | Tools and Technologies II | Developing a method for rapid identification of high-quality disease specific hIPSC lines | $1,816,157 |
| University of California, Davis | Walter Boyd | Early Translational III | Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair | $4,939,140 |
| Sanford-Burnham Medical Research Institute | Huei-sheng Chen | Basic Biology II | Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes | $1,823,362 |
| Samumed, LLC | John Hood | Disease Team Therapy Planning I | Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures | $99,110 |
| University of California, Los Angeles | Brigitte Gomperts | New Faculty II | Stem Cells in Lung Cancer | $2,556,572 |
| University of California, San Diego | Cornelis Murre | SEED Grant | Generation of long-term cultures of human hematopoietic multipotent progenitors from embryonic stem cells | $538,211 |
| University of California, Santa Cruz | Margaret Delaney | Major Facilities | No Title | $7,191,950 |
| Stanford University | Renee Reijo Pera | Research Training II | CIRM Training Program | $7,974,291 |
| University of California, San Francisco | Barbara Panning | Basic Biology IV | Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming | $1,285,214 |
| University of California, San Diego | Binhai Zheng | Basic Biology III | Generation and characterization of corticospinal neurons from human embryonic stem cells | $1,355,063 |
| Scripps Research Institute | Martin Friedlander | Early Translational I | Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration | $5,945,738 |
| University of California, San Diego | Mana Parast | New Faculty II | Molecular Mechanisms of Trophoblast Stem Cell Specification and Self-Renewal | $3,253,580 |
| University of California, Irvine | Frank LaFerla | SEED Grant | Development of human ES cell lines as a model system for Alzheimer disease drug discovery | $492,750 |
| University of California, Irvine | Leslie Thompson | Disease Team Planning | Huntington's Disease Team | $54,618 |
| Children's Hospital of Los Angeles | David Warburton | Shared Labs | hESC Facility | $3,756,666 |
| California Polytechnic State University, San Luis Obispo | Trevor Cardinal | Bridges | Masters of Science Specialization in Stem Cell Technology | $3,020,182 |
| University of California, Davis | Mark Zern | Early Translational II | Liver Cell Transplantation | $5,199,767 |
| University of California, Davis | William Murphy | Transplantation Immunology | Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance | $1,317,569 |
| University of California, San Diego | Yang Xu | Comprehensive Grant | Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells | $2,570,000 |
| University of California, Davis | A. Reddi | SEED Grant | hESCs for Articular Cartilage Regeneration | $367,650
| University of California, San Francisco | Susan Fisher | New Cell Lines | Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines | $1,383,419 |
| The Parkinson's Institute | Dennis Steindler | Research Leadership 10 | Stem Cell Pathologies in Parkinson’s disease as a key to Regenerative Strategies | $6,718,471 |
| University of Southern California | Andrew McMahon | Research Leadership 10 | Repair and regeneration of the nephron | $5,672,206 |
| University of California, San Diego | Dennis Carson | Disease Team Research I | Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) | $19,999,826 |
| University of California, Davis | Vicki Wheelock | Disease Team Therapy Development - Research | MSC engineered to produce BDNF for the treatment of Huntington's disease | $18,950,061 |
| Scripps Research Institute | Peter Schultz | Training Grant I-2 | Training Grant I | $1,059,300 |
| University of California, Los Angeles | Michael Phelps | Tools and Technologies I | Novel Tools and Technologies for Translational PET Imaging of Cell-based Therapies | $914,096 |
| University of California, Irvine | Grant MacGregor | SEED Grant | Production of Oocytes from Human ES Cells | $623,781 |
| University of California, Davis | Emanual Maverakis | New Faculty Physician Scientist | Tunable hydrogels for therapeutic delivery of multipotent stem cells. | $3,139,000 |
| Stanford University | Brian Rutt | Tools and Technologies II | Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters | $1,930,608 |
| University of California, San Francisco | Katherine Nielsen | Creativity Awards | [REDACTED] SEP High School Intern Program | $143,550 |
| University of California, Los Angeles | Robb Maclellan | Basic Biology I | Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate | $1,378,076 |
| University of California, San Diego | Yang Xu | Early Translational III | Human ES cell based therapy of heart failure without allogenic immune rejection | $1,857,600 |
| University of California, Los Angeles | Kathrin Plath | New Faculty I | In vitro reprogramming of mouse and human somatic cells to an embryonic state | $2,229,427 |
| The J. David Gladstone Institutes | Fen-Biao Gao | SEED Grant | MicroRNAs in Human Stem Cell Differentiation and Mental Disorders | $791,000 |
| University of Southern California | Martin Pera | New Cell Lines | New Technology ForThe Derivation of Human Pluripotent Stem Cell Lines For Clinical Use | $1,387,508 |
| GMR Epigenetics | Jifan Hu | Tools and Technologies II | Robust generation of induced pluripotent stem cells by a potent set of engineered factors | $1,452,693 |
| University of Southern California | Toshio Miki | Early Translational III | Generation of hepatic cell from placental stem cell for congenital metabolic disorders | $1,750,375 |
| University of California, San Francisco | John Rubenstein | Basic Biology II | MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells | $1,387,800 |
| OncoMed Pharmaceuticals, Inc. | Timothy Hoey | Disease Team Therapy Planning I | [REDACTED]: A New Cancer Therapeutic to Reduce CSC Frequency | $65,120 |
| Ludwig Institute for Cancer Research | Bing Ren | New Faculty II | Mechanisms of chromatin dynamics at enhancers during ES cell differentiation | $1,726,564 |
| Sanford-Burnham Medical Research Institute | Robert Oshima | SEED Grant | Trophoblast differentiation of human ES cells. | $748,240 |
| University of California, San Francisco | Jeffrey Bluestone | Disease Team Planning | A CIRM Disease Team for the Treatment and Cure of Diabetes | $55,000 |
| Buck Institute for Age Research | David Greenberg | Research Training II | CIRM Research Training Program in Stem Cells and Aging | $3,178,692 |
| University of California, Berkeley | Robert Tjian | Basic Biology IV | Transcriptional regulation of pluripotency in human embryonic stem cells | $1,220,968 |
| University of California, Los Angeles | Yi Sun | Basic Biology III | Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo | $1,382,400 |
| The J. David Gladstone Institutes | Warner Greene | Early Translational I | Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation | $1,327,973 |
| University of California, San Francisco | Ophir Klein | New Faculty II | Laying the groundwork for building a tooth: analysis of dental epithelial stem cells | $3,250,251 |
| University of California, San Francisco | Linda Giudice | SEED Grant | Human Embryonic Stem Cell Differentiation to Trophoblast: Basic Biology and Clinical Translation to Improve Human Fertility | $640,399 |
| Children's Hospital of Los Angeles | Donald Kohn | Disease Team Planning | STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE | $33,110 |
| University of Southern California | Andrew McMahon | Shared Labs | Center for Stem Cell and Regenerative Medicine: Shared Research Laboratory and Course in Current Protocols in Human Embryonic Stem Cell Research | $5,355,969 |
| California State Polytechnic University, Pomona | Jill Adler-Moore | Bridges | Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education | $3,008,975 |
| University of California, Los Angeles | Noriyuki Kasahara | Early Translational II | Stem cell-based carriers for RCR vector delivery to glioblastoma | $3,370,607 |
| Stanford University | Christopher Contag | Transplantation Immunology | Engineering Embryonic Stem Cell Allografts for Operational Tolerance | $1,447,956 |
| Stanford University | Julie Baker | Comprehensive Grant | Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cell | $2,628,635 |
| University of Southern California | Pin Wang | Tools and Technologies I | Development of Baculoviral Vectors for Gene Editing of Human Stem Cells | $951,104 |
| The J. David Gladstone Institutes | Robert Farese | New Cell Lines | Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations | $1,708,560 |
| The Salk Institute for Biological Studies | Fred Gage | New Cell Lines | Development of Induced Pluripotent Stem Cells for Modeling Human Disease | $1,737,720 |
| Stanford University | Michael Longaker | Training Grant I-1 | Stanford CIRM Training Program | $3,733,707 |
| Stanford University | Alfred Lane | Disease Team Research I | iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa | $11,709,574 |
| Cedars-Sinai Medical Center | Clive Svendsen | Disease Team Therapy Development - Research | Progenitor Cells Secreting GDNF for the Treatment of ALS | $17,842,617 |
| The J. David Gladstone Institutes | Robert Mahley | Training Grant I-2 | Gladstone CIRM Scholar Program | $2,397,240 |
| Vala Sciences, Inc. | Patrick McDonough | Tools and Technologies I | Optimization in the Identification, Selection and Induction of Maturation of Subtypes of Cardiomyocytes derived from Human Embryonic Stem Cells | $906,629 |
| University of California, Riverside | Michael Pirrung | SEED Grant | Stem Cell Survival and Differentiation Through Chemical Genetics | $543,987 |
| University of California, Los Angeles | Ali Nsair | New Faculty Physician Scientist | Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. | $3,179,315 |
| Stanford University | Irving Weissman | Tools and Technologies II | Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs | $1,869,487 |
| University of California, Los Angeles | Gay Crooks | Basic Biology III | Forming the Hematopoietic Niche from Human Pluripotent Stem Cells | $1,375,983 |
| University of California, Davis | Min Zhao | Basic Biology I | Directing migration of human stem cells with electric fields | $1,052,715 |
| University of California, San Diego | Eugene Yeo | Early Translational III | Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons | $1,654,830 |
| University of Southern California | Songtao Shi | New Faculty I | Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells | $3,428,464 |
| University of California, Los Angeles | Noriyuki Kasahara | SEED Grant | Down-Regulation of Alloreactive Immune Responses to hES Cell-Derived Graft Tissues | $469,219 |
| Cedars-Sinai Medical Center | Barry Stripp | Research Leadership 12 | Epithelial progenitors and the stromal niche as therapeutic targets in lung disease | $4,841,830 |
| University of California, Berkeley | David Schaffer | Tools and Technologies II | Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs | $1,493,928 |
| Children's Hospital of Orange County | Philip Schwartz | Early Translational III | Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease | $5,509,978 |
| Stanford University | Garry Nolan | Basic Biology II | Kinase signaling analysis of iPS cell reprogramming and differentiation | $1,447,956 |
| University of California, Davis | Nancy Lane | Disease Team Therapy Planning I | Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis | $110,000 |
| University of California, San Diego | Shyni Varghese | New Faculty II | A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment | $2,300,569 |
| The Salk Institute for Biological Studies | Samuel Pfaff | SEED Grant | Gene regulatory mechanisms that control spinal neuron differentiation from hES cells. | $807,749 |
| University of Southern California | David Woodley | Disease Team Planning | Clinical Regenerative Wound Healing With Stem Cells | $42,574 |
| University of Southern California | Robert Maxson | Research Training II | CIRM Stem Cell Biology Training Program | $6,162,053 |
| Stanford University | Anne Brunet | Basic Biology IV | Energy metabolism and aging pathways in human stem cell reprogramming and differentiation | $1,414,044 |
| The J. David Gladstone Institutes | Deepak Srivastava | Basic Biology III | Mechanisms of Direct Cardiac Reprogramming | $1,708,560 |
| The Jackson Laboratory West | Pali Kaur | Early Translational I | Mouse Models for Stem Cell Therapeutic Development | $3,841,240 |
| University of California, San Francisco | Emmanuelle Passegue | New Faculty II | Mechanisms Underlying the Responses of Normal and Cancer Stem Cells to Environmental and Therapeutic Insults | $2,274,368 |
| University of California, San Diego | Shu Chien | SEED Grant | Combinatorial Platform for Optimizing Microenvironments to Control hESC Fate | $638,140 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Disease Team Planning | "Stem Cell Therapies for Heart Failure" | $53,150 |
| University of California, San Francisco | Linda Giudice | Shared Labs | Shared Research and Teaching Laboratory: a Non-Federal Human Embryonic Stem Cell Resource for the Bay Area Community | $5,546,877 |
| California State University, Channel Islands | Ching-Hua Wang | Bridges | Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at (REDACTED) and Co-development of a GE Course on Stem Cel | $3,614,553 |
| University of California, San Diego | Catriona Jamieson | Early Translational II | Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy | $3,341,758 |
| Cedars-Sinai Medical Center | Terrence Town | Transplantation Immunology | Role of HLA in neural stem cell rejection using humanized mice | $1,472,634 |
| University of California, San Francisco | Harold Bernstein | Comprehensive Grant | Modeling Myocardial Therapy with Human Embryonic Stem Cells | $2,229,140 |
| University of California, Irvine | Lisa Flanagan | Tools and Technologies I | Novel Separation of Stem Cell Subpopulations | $871,627 |
| University of California, San Francisco | Long-cheng Li | New Cell Lines | Induction of pluripotent stem cells by small RNA-guided transcriptional activation | $1,375,144 |
| University of California, San Francisco | Susan Fisher | Training Grant I-1 | Training Grant I | $3,620,652 |
| Beckman Research Institute of City of Hope | Karen Aboody | Disease Team Research I | Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials | $18,015,429 |
| StemCells, Inc. | Alexandra Capela | Disease Team Therapy Development - Research | Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy | $20,000,000 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Training Grant I-2 | Burnham Institute CIRM Stem Cell Training Grant (Type II) | $1,489,640 |
| University of California, Berkeley | Steven Conolly | Tools and Technologies I | Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scannerfor Tracking Stem Cells In Vivo | $882,430 |
| Sanford-Burnham Medical Research Institute | Huei-sheng Chen | SEED Grant | Development of Neuro-Coupled Human Embryonic Stem Cell-Derived Cardiac Pacemaker Cells. | $744,639 |
| Stanford University | Alan Cheng | New Faculty Physician Scientist | Enhancing hair cell regeneration in mouse and human inner ear | $3,266,595 |
| University of California, Los Angeles | Richard Gatti | Tools and Technologies II | Use of hiPSCs to develop lead compounds for the treatment of genetic diseases | $1,833,054 |
| Beckman Research Institute of City of Hope | Jiing-Kuan Yee | Basic Biology III | Use of human iPS cells to study spinal muscular atrophy | $1,268,868 |
| University of Southern California | Wange Lu | Basic Biology I | Defining the molecular mechanisms of somatic cell reprogramming | $1,468,360 |
| University of California, San Francisco | Arnold Kriegstein | Early Translational III | Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury | $1,623,251 |
| Beckman Research Institute of City of Hope | Tiziano Barberi | New Faculty I | Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy | $1,623,064 |
| University of California, San Francisco | Heike Daldrup-Link | SEED Grant | Labeling of human embryonic stem cells with iron oxide nanoparticles and fluorescent dyes for a non-invasive cell depiction with MR imaging and optical imaging | $251,088 |
| The J. David Gladstone Institutes | Kevin Parker | Research Leadership 12 | Engineering Cardiac Tissue for Regeneration and Drug Development | $7,480,036 |
| University of California, Los Angeles | Martin Martin | Tools and Technologies II | Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders | $1,783,250 |
| University of California, Davis | Kyriacos Athanasiou | Early Translational III | Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells | $1,735,703 |
| University of California, Irvine | Aileen Anderson | Basic Biology II | Role of the microenvironment in human iPS and NSC fate and tumorigenesis | $1,284,921 |
| Cedars-Sinai Medical Center | Dan Gazit | Disease Team Therapy Planning I | Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. | $109,743 |
| University of California, San Francisco | Robert Blelloch | New Faculty II | Mechanisms of small RNA regulation in early embryonic development | $3,204,897 |
| University of California, Los Angeles | Michael Teitell | SEED Grant | Role of Mitochondria in Self-Renewal Versus Differentiation of Human Embryonic Stem Cells | $635,024 |
| University of California, San Francisco | Jeffrey Lotz | Disease Team Planning | A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage | $55,000 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Research Training II | Type III CIRM Stem Cell Research Training Program | $2,856,694 |
| Stanford University | Michael Cleary | Basic Biology IV | Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells | $1,244,455 |
| University of California, San Diego | Eugene Yeo | Basic Biology III | Neural and general splicing factors control self-renewal, neural survival and differentiation | $1,372,660 |
| The Parkinson's Institute | J. William Langston | Early Translational I | Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson's disease research and drug discovery | $3,701,766 |
| University of Southern California | Qilong Ying | New Faculty II | Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation | $2,413,650 |
| The Salk Institute for Biological Studies | Senyon Choe | SEED Grant | A method to maintain and propagate pluripotent human ES cells | $796,348 |
|